|Day Low/High||5.56 / 5.85|
|52 Wk Low/High||3.43 / 19.80|
Trade-Ideas LLC identified Galena Biopharma (GALE) as a "perilous reversal" (up big yesterday but down big today) candidate
Investors in Galena Biopharma Inc saw new options become available today, for the January 2016 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 784 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Upgrades: AGO, BBGI, BKMU, CODI, EME, FONR, LPI Downgrades: ADNC, AUQ, CYD, DATE, DPZ, EROC, FSP, LBTYB, LBTYK, LYV, NPSP, RLJ, SF, SHO Initiations: ANFI, GALE, RLGY Read on to get TheStreet Quant Ratings' detailed report:
Investors in Galena Biopharma Inc saw new options begin trading this week, for the December 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GALE options chain for the new December 21st contracts and identified one put and one call contract of particular interest.
First Commercial Product for Galena Biopharma Available Nationwide
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
Biotech columnist Adam Feuerstein answers readers' questions about healthcare companies.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.